Virtual Auditorium 3

Introduction of the Guideline for Pharmacological Therapy of SchizophreniaHiroyuki Uchida, Japan   Implementing Evidence-Based Practices for People with Schizophrenia in JapanKenji Sakuma, Japan   Pharmacological Treatment of Relapse/Recurrence in Patients with SchizophreniaHikaru Hori, Japan   Maintenance Treatment of SchizophreniaHiroyoshi Takeuchi, Japan   Treatment Resistance SchizophreniaRyota Hashimoto, Japan      Chairperson: Ryoto Hashimoto This symposium is …

Pharmacological Strategies in Complex ADHDTimothy E Wilens, USA Advanced psychopharmacologic treatment for Child and Adolescent with Autism Spectrum DisorderJoshi Gagan, USA Chairperson: John Wong, Singapore This session is made possible by kind support from Hyphens.

Optimizing Treatment for Patients with SchizophreniaAhmad Hatim B Sulaiman, Malaysia Effect of Adjuvant Vitamin C on Brain-Derived Neurotrophic Factor (BDNF) Levels and Improvement of Negative Symptoms in Schizophrenic PatientsKristian Liaury, Indonesia Recent Trend in Neuropsychopharmacology in JapanNorio Yasui-Furukori, Japan Profiles of antipsychotic use among schizophrenia patients in Indonesia: Results from the REAP StudyAndi Tanra, Indonesia …

The impact of COVID-19 on the treatment model of mental disorders  Li Yi, China Mental health outcomes among patients exposed to COVID-19 : Experience from Fangcang shelter hospitalGuangyin Zhang, China Lessons Learned from Covid-19 Pandemic: Indonesia’s PerspectiveAndi J Tanra, Indonesia Health Care Worker Wellness During Covid-19: The New Normal in SingaporeTji Tijan Chee, Singapore The …